Do COVID Treatments Need Better Media Coverage?
Awareness of Paxlovid, PAXCESS Assistance Program Could Be Aided By Journalists, Experts Say
Only 15% of high-risk COVID patients eligible for Paxlovid took it, an NIH study found. Four experts joined a National Press Foundation webinar to tackle awareness and access around antivirals.
‘Is My COVID Vaccine Covered?’ It Should Be.
The COVID Vaccine is Recommended by ACIP. Now What?
For updated COVID vaccine access, pharmacies will be where the “friction” is in the weeks ahead, doctor says.
APEC Trade Not Immune from External Forces
Trade Still Recovering from Pandemic Plunge
Even weather can disrupt trade, says Carlos Kuriyama of the Asia-Pacific Economic Cooperation.
Long COVID in Children: An Open Question
Diagnosing and Treating Long COVID in Children from all Backgrounds
Is long COVID menacing American children? University Hospitals pediatric researchers Amy Edwards and David Miller explore an important new angle in child health.
The Cost of COVID: Education Funding Explained
Quantifying School Spending — and the Toll Extracted by the Pandemic
What journalists should know covering U.S. learning loss. Ash Dhammani of Georgetown’s Edunomics Lab how to use the first-ever spending database for public schools.
Beyond the Blotter: Understanding Crime Trends
Journalists Must Look Beyond Crime Rates To Clearance Rates
“There's a ton of context in criminal justice which is getting lost, in my opinion, as a result of that need for urgency,” in TV news, said Walter Katz, vice president of criminal justice at Arnold Ventures with a 17-year tenure as a public defender.
As Workplace Mental Health Worsens, Some Companies Step Up
Need a Mental Health Day?
Toxic bosses, burnout, turnover and unionization prompt new emphasis on workplace well-being.
The Intersectionality of Aging
Journalists Must Look More Closely at the Diverse, Aging Workforce
Ageism doesn’t exist in a vacuum. Experts from the Trust for America’s Health and the Urban Institute discuss how the intersectionality of race, sex, ability and wealth also matter.
Age Discrimination is Pervasive, Says AARP Chief Public Policy Officer
Social Security Isn’t Going Bankrupt, But Large Fraction of Aging Americans at Risk
Age discrimination, caregiving crisis are under-covered stories that audiences care about deeply, policy expert Debra Whitman argues.
Fauci on Monkeypox: ‘We Have a Problem Here’
Dr. Anthony Fauci Says Not Enough Is Known About Monkeypox Or Long COVID
The U.S. doesn’t “have a handle” on monkeypox spread due to a lack of testing, Dr. Anthony Fauci said in a National Press Foundation exclusive briefing.
Reporting on Kids and the COVID Vaccine
Cutting Through Misinformation
Tips for reporters covering the coronavirus vaccine for children — and how it will impact families, schools and more.
The Future of Commuting, Post-Pandemic
The return of millions of workers to the office will test highways, subways and bus systems.
It may take incentives like free fares to lure people back to using mass transit. Kansas City and Los Angeles are experimenting with free fares on public transit to get people back.
Back-to-School in a Pandemic World
Masking, Vaccine Issues Vex Schools
With the rapid surge of the Delta variant, schools are implementing COVID-19 vaccine mandates for teachers and students in an attempt to slow the spread. What new obstacles are teachers, students and families facing?
Vaccine Passports: Ethics and Inequality
Pro Tip: Call them “immunization credentials,” experts advise
Some experts call for U.S. digital credential to prove vaccine status, but others warn it could increase inequality and discrimination.
Two New Tools for Reporting on Vaccine Access and Information Needs
They Might Not Tell Their Boss or Doctor, But People Confide in Google.
Google and public health officials have developed tools reporters can use to pinpoint “vaccine deserts” and communities where people are searching about vaccine side effects.
Pandemic Crime Wave: Causes and Responses
New Wave of Violence Triggers Political and Police Turmoil
Crime has become a top issue in local elections after a steep rise in violent crime in the past year. While property crime is down, homicides in big cities are up 30%. A panel of experts explains why — and what can be done about it.
Who Got Those Federal Contracts?
ProPublica Reporter Explains How to Follow the Dollars on Federal COVID Contracts
Government contractors were paid $38 billion to supply everything from vaccines to surgical gowns. Several untested firms struggled to deliver their orders. Here’s how to track the money.
How to Track Trillions in COVID Relief
Using PPP and Other Data to Pinpoint Who Got Stimulus Money
Good Jobs First has built a data storehouse that compiles payments to companies, as well as whether recipients of taxpayer money have run afoul of laws or regulations. POGO has built a COVID tracker that shows trillions in other pandemic spending. Here’s how to use both sites.
Fixing Broken Medical Supply Chains
Journalists can use new tools to track shortages of medical goods – or anything else.
COVID showed that no country can go it alone in battling a pandemic. Experts say supply chains are bouncing back, but “medical nationalism” is still in play. Would “trusted supply chains” help ensure heath security?
How COVID is Hurting State Budgets
Damage Isn’t as Severe as Feared, But States Still Struggle With COVID-Fueled Revenue Shortfalls
Unlike the federal government, states must balance their budgets each year. They are scrambling to cover the COVID budget gap.
Mental Anguish in the Pandemic Workplace
Interplay Between Physical and Mental Health Critical for Employers to Understand. What to Do?
Even before the pandemic, mental health problems were costing businesses up to $200 billion a year in absenteeism, lost productivity and physical ailments. A Johns Hopkins mental health expert says a well-designed health system would yield a huge return on investment for employers.
The Political Battle Over Paid Leave
As COVID-19 Ravages the Economy, Paid Leave Can Help Mitigate Damage
Paid sick days and paid leave can help families weather a crisis or pandemic, but workers in much of the country don’t get them. Will the new Congress change that?
FDA Adviser: Time to Trust the Coronavirus Vaccine
FDA’s Emergency Approval Process Will Ensure Faster Access to Coronavirus Vaccine
A leading vaccine specialist says it’s time to put aside distrust in the process that should get a coronavirus vaccine to most Americans’ arms by spring.
How COVID Will Change the Suburbs
As People Flee Congestion and the Virus, Suburbs Stand to Gain
From New York to Mumbai, COVID fears have sent people scrambling out of cities and elevated suburban housing prices. Whether that trend will hold is uncertain, but the pandemic has accelerated calls to “retrofit suburbia” to make it greener, more prosperous and healthier.
When the Government Bails Out the Economy
Putting the $4 Trillion COVID Bailout in Historical Context
From the Great Depression to the COVID pandemic, the U.S. has had mixed results trying to rescue the economy.
Media Lawsuit Demands COVID Data
News Organizations Still Demand Full Disclosure from SBA
News organizations have sued the federal government for full access to Paycheck Protection Program spending. Their lawyer says SBA disclosures are inadequate.
NPF Guide to Tracking COVID Cash
Investigative and Data Journalism Tips for Following the Pandemic Stimulus Money
NPF has published a guidebook to help journalists track taxpayer spending on pandemic relief. It includes useful databases, videos on how to use Excel, Python and other data tools and pro tips from leading investigative journalists.
Using Excel to Drill Into PPP Data
A Step-By-Step Guide to Analyzing COVID-19 PPP Data by State
Excel tips: How to use pivot tables, filters and the VLOOKUP function to zero in on COVID small business relief loans in your state.
COVID Cash and the Debt
What the huge infusion of federal money means for the nation’s long-term fiscal health.
The federal government has committed trillions to prop up the economy. How – and when – will it eventually pay for it?
The Ethics Behind Vaccine Trials
How Emergency Use Authorization, Human Challenge Affect COVID Vaccine
After seven months of restrictions, many are eager to develop and distribute COVID-19 vaccines quickly. But a top ethicist warns that sacrificing speed for safety might not be the best bet.
Tracking the Anti-Vaccination Movement
About a quarter of Americans say they wouldn't get a coronavirus vaccine.
Social media messaging urging U.S. citizens to reject vaccination has roughly tripled since the COVID-19 pandemic began and is now driving an increase in public suspicions of vaccines.
A New Tool for Tracking COVID Cash
Volunteer Data Scientists Create Tool for Journalists
A group of data scientist volunteers has produced a new set of databases designed to make it easier for journalists to track federal pandemic stimulus funding.
The Virus’ Long Timetable
Masking Up for the Long Haul: COVID-19 Won’t Go Away Quickly
The coronavirus isn’t going away anytime soon, meaning that Americans will need to remain masked up and socially distant until late 2021 – even with an approved vaccine, according to one of the nation’s top infectious disease specialists.
Three Tools for Tracking COVID Cash
Updated tools to help reporters follow the pandemic stimulus money.
Millions of small and large businesses received COVID-fueled contracts and bailouts. Experts detail how to use three tracking tools to see who those companies are.
A “Perfect Storm for Death”
The World’s Poor Have Been Hit Hardest by COVID, Reflecting Longstanding Health Trends
Leading public health experts Sir Michael Marmot and Dr. Otis Brawley detail the connection between poverty and poor health. Life expectancy for some Americans is dropping.
How Poverty and COVID Shape Children’s Lives
Before COVID, Childhood Poverty Was a Major Problem. It’s Only Gotten Worse.
Since COVID hit, researchers have pivoted to document how isolation, financial shocks and increased stress have affected children and their families.
Vaccine Approval 101
FDA Vows to Maintain Standards for COVID Vaccine
Dr. Peter Marks, director of the FDA’s vaccines division, briefs NPF fellows on the hazards of expediting a coronavirus vaccine while also maintaining rigorous safety standards. Interactive transcript available.
The Effects of Vaccine Hesitancy
Coronavirus Vaccine Faces Early Battle Against Growing Pockets of Resistance
Despite successes in the lab and well-documented safety, vaccines face a growing number of skeptics. Will that imperil any coronavirus vaccine?
Tracking the People Receiving Loans
Top Investigative Reporters Offer Tips and Strategy on Backgrounding Businesses
The U.S. government has pushed out nearly 5 million small business loans. Learn how to find more about them.
Documenting Federal COVID Contracts
ProPublica Dashboard on Federal Contracts Helps Reporters Probe Coronavirus Spending
A data journalist details how he built a dashboard of every COVID-related government contract.